Astal Laboratories Ltd Financials
Company Logo

Astal Laboratories Ltd Financial Statement

Astal Laboratories Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Jun 2024
Revenue13.18
Operating Expense10.77
Net Profit1.69
Net Profit Margin12.82
Earning Per Share1.72
EBIDTA2.38
Effective Tax Rate25.73

Astal Laboratories Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Total Revenue Annual23.65
Operating Expenses Annual22.53
Operating Profit Annual1.13
Interest Annual0.01
Depreciation0.03
Net Profit Annual0.78
Tax Annual0.30

Astal Laboratories Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Cash Flow at the Beginning0.08
Cash Flow from Operations-5.59
Cash Flow from Investing-6.11
Cash Flow from Financing17.69
Cash Flow at the End6.08

Astal Laboratories Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
PBDIT Margin (%)4.78
PBIT Margin (%)4.65
PBT Margin (%)-456.24
Net PROFIT Margin (%)3.30
Return On Networth / Equity (%)5.47
Return On Networth /Employed (%)7.56
Return On Assets (%)5.41
Total Debt / Equity (X)0.01
Asset Turnover Ratio (%)1.64

Astal Laboratories Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Fixed Assets Annual0.69
Total Current Assets Annual26.73
Non Current Assets Annual9.89
Total Shareholders Funds Annual23.34
Total Assets Annual36.61

Astal Laboratories Ltd Earning Calls

No Data Availabe

Get Your FAQs Right

As of Sep 19, 2024, Astal Laboratories Ltd has a market capitalization of 40.19 Cr. Value Research classifies it as a Micro-Cap company.
Yes, Astal Laboratories Ltd is debt-free with a debt-to-equity ratio of 0.01.
In FY 2023 , Astal Laboratories Ltd recorded a total revenue of approximately 23.65 Cr marking a significant milestone in the company's financial performance.
Astal Laboratories Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.9% and Infinity% annually, respectively..
Astal Laboratories Ltd's current PE ratio is 51.53.
Astal Laboratories Ltd's ROCE averaged 1.6% from the FY ending March 2022 to 2024, with a median of 0.6%. It peaked at 4.6% in March 2024, reflecting strong capital efficiency over the period..
Astal Laboratories Ltd's latest EBIT is Rs. 1.10 Cr, surpassing the average EBIT of Rs. 0.37 Cr over the 5 years..